Literature DB >> 5364387

Dermonecrotic factor. II. Frequency and clinical correlations of dermonecrotic factor in severe hypertension.

A Ebringer, A E Doyle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5364387      PMCID: PMC2072180     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


× No keyword cloud information.
  8 in total

1.  Sensitisation of blood-vessels to hypertensive damage by x-irradiation.

Authors:  A W ASSCHER; C WILSON; S G ANSON
Journal:  Lancet       Date:  1961-03-18       Impact factor: 79.321

2.  Necrotizing factor in human sera.

Authors:  F KLEMPERER; R FRIED; K STARK
Journal:  Br J Exp Pathol       Date:  1962-04

3.  Further studies into the human serum factor which causes necrosis of guinea-pig skin.

Authors:  D E SCHAFFER
Journal:  Ann Allergy       Date:  1957 Sep-Oct

4.  The clinical course and pathology of hypertension with papilloedema (malignant hypertension).

Authors:  P KINCAID-SMITH; J McMICHAEL; E A MURPHY
Journal:  Q J Med       Date:  1958-01

5.  The necrotic lesion in guinea-pig skin produced by certain human sera.

Authors:  R R LOVELL; D M PRYCE; W C BOAKE
Journal:  Br J Exp Pathol       Date:  1954-08

6.  The necrotizing activity of human sera for guinea-pig skin.

Authors:  W C BOAKE; R R LOVELL
Journal:  Br J Exp Pathol       Date:  1954-08

7.  Lung cancer: a survey of 100 consecutive cases with histological confirmation.

Authors:  R Elliott; J Wright; J B Johnston
Journal:  Med J Aust       Date:  1968-04-20       Impact factor: 7.738

8.  Dermonecrotic factor. I. Nature and properties of a dermonecrotic factor to guinea-pig skin found in human serum.

Authors:  A Ebringer; A E Doyle; G S Harris
Journal:  Br J Exp Pathol       Date:  1969-12
  8 in total
  1 in total

1.  Dermonecrotic factor. I. Nature and properties of a dermonecrotic factor to guinea-pig skin found in human serum.

Authors:  A Ebringer; A E Doyle; G S Harris
Journal:  Br J Exp Pathol       Date:  1969-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.